New leadership at MIT’s Center for Biomedical Innovation
Stacy Springs named executive director; Richard Braatz is associate faculty director.
Stacy Springs named executive director; Richard Braatz is associate faculty director.
Rapid and accurate analytical test method enhances the production of high-quality cell therapy products.
Report offers guidelines to help prevent viruses from tainting biopharmaceutical drugs.
Seven-month program includes 14 international groups, who are convening at the Institute to develop new biomedical technologies.
The School of Engineering gives its 2018 Infinite Mile Awards for exceptional service and support.
NEWDIGS Initiative at MIT leads multi-stakeholder collaboration to design and pilot a sustainable, patient-centered innovation ecosystem for a target disease.
Industry leaders, patient advocates, and policymakers collaborate to make groundbreaking new therapies economically sustainable.
The School of Engineering gives its 2017 Infinite Mile Awards for exceptional service and support.
Industry leaders, patient advocates, and policymakers collaborate to lower barriers to potentially curative treatments.
Twelve finalist teams pitched diverse new health care technologies at MIT.
Pharma veteran and MIT visiting scientist Mark Trusheim advances a provocative solution to overcome treatment costs.
Team announces collaboration with the Walmart Foundation.
Stacy Springs and Shannon Stewart identify trends related to U.S. research and development funding and policy.
Stephen Miles helps to bring the benefits of serialized identification systems to translational medicine and research.
Focusing on biologics manufacturing, new course will be part of edX online learning platform.